Linking Novel Medicines to Patients with Hard-to-Treat Cancers for Improved Quality of Life

Usama Malik and Loretta Itri, M.D., explain how Immunomedics has built a differentiated ADC platform using a proprietary linker and some unique targets.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: